Payer-type (government-sponsored health coverage versus private health insurance) has been shown to influence a variety of cardiovascular disease outcomes in adults. However, it is unclear if the payer-type impacts the response to a lifestyle intervention in children with dyslipidemia. | The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia